Yiyang Wang

After my first year of success, I was asked to lead the upmarket and medical vertical team which became a building block for the company’s 2023 and beyond strategy. As someone who leads by example, I managed the highest revenue generating team in the company and closed historic deals with them side by side.

• FY22: 101% to goal (after company-wide riff which affected ⅓ of team)
• FY23: 120% to goal, closed initial upmarket new framework (HITRUST) deals to carry quota while top AE was out for maternity leave
• FY24 Q1: 137% to goal, collaborated with top AE to close and onboard the biggest deal in company history (HITRUST)
• Created training and strategies to sell a new compliance framework - HITRUST, increased lead flow and revenue by developing relationship with the HItRUST governing body, and helped Thoropass plant the flag as the number one company in the space for health technology businesses.

• FY 2016 (SDA): Assisted with special projects and territory expansion
• FY 2017-2019 (AE, Sr. AE): President's Club 2018, 2019, 342% to first year quota, 170% of second year quota, 146% to third year quota all whilst leading 60%, the Asian Employee Resource Group
• FY 2019-2020 (Team Lead): I managed four Account Executives and sold alongside them while holding a senior AE quota (reduced by 25%). 110% average to goal in Q1-Q3 (Q4 dipped to 30% due to COVID). Hit annual personal quota halfway through the year in order to focus on team
• FY 2021-2022 (Sales Manager): 114% to first year target, 126% to second year target